This inventor holds 1 USPTO granted patent. Top assignee: University of Rochester. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Michael Hoffman: Innovator in Stem Cell Proliferation
Introduction
Michael Hoffman is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of stem cell research, particularly in the proliferation of mesenchymal stem cells. His innovative methods have the potential to advance therapeutic applications in regenerative medicine.
Latest Patents
Hoffman's most recent patent is titled "Methods and compositions for mesenchymal stem cell proliferation." This patent describes a method for increasing the proliferation of mesenchymal stem cells by contacting the cells with 6-bromoindirubin-3'-oxime (BIO). The results indicate robust proliferation and enhanced 'stemness' in a dose-dependent manner, as evidenced by the gene expression of two critical stem cell genes: Sox2 and Nanog. This patent highlights Hoffman's commitment to advancing scientific knowledge and practical applications in stem cell biology.
Career Highlights
Michael Hoffman is affiliated with the University of Rochester, where he conducts his research and development. His work has garnered attention for its innovative approach to stem cell proliferation, which is crucial for various medical applications. Hoffman's dedication to his field is evident in his research endeavors and the impact of his findings.
Collaborations
Hoffman collaborates with Danielle Benoit, a fellow researcher, to explore further advancements in stem cell technology. Their partnership exemplifies the collaborative spirit of scientific research, aiming to push the boundaries of what is possible in regenerative medicine.
Conclusion
Michael Hoffman is a pioneering inventor whose work in mesenchymal stem cell proliferation is paving the way for future advancements in regenerative medicine. His contributions are vital to the ongoing research in this promising field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
